Bacterial vaginosis (BV) is caused by a shift in the vaginal microbiome: the protective bacteria that normally dominate are outgrown by a mix of anaerobic organisms, leading to symptoms like fishy odor, thin discharge, and irritation. Globally, somewhere between one in five and one in three women of reproductive age are affected at any given time, making it the most common vaginal condition. But the story behind what triggers that microbial shift, and what you can actually do about it, turns out to be more layered than a simple infection-and-cure model would suggest.
How a Healthy Vaginal Microbiome Works
Under normal conditions, the vagina is dominated by Lactobacillus species, which can make up over 70% of the microbial community. These bacteria produce lactic acid, hydrogen peroxide, and antimicrobial compounds called bacteriocins that keep the vaginal pH low (below about 4.5) and suppress the growth of harmful organisms.1PubMed Central. The role of probiotics in vaginal health That acidic, Lactobacillus-rich environment is essentially a defense system. When it stays intact, opportunistic bacteria are kept in check.
Not all Lactobacillus strains are equal in this role. The ones that produce hydrogen peroxide appear to be especially protective. In a study of pregnant women, hydrogen-peroxide-producing lactobacilli were found in 61% of women with normal vaginal flora but in only 5% of women diagnosed with BV.2Clinical Infectious Diseases. The Normal Vaginal Flora, H2O2-Producing Lactobacilli, and Bacterial Vaginosis in Pregnant Women Non-peroxide-producing lactobacilli were equally common regardless of BV status, suggesting they do not provide the same level of protection. So the type of Lactobacillus matters, not just whether lactobacilli are present at all.
What Happens When Things Go Wrong
BV is not caused by a single invading pathogen the way a strep throat or urinary tract infection might be. Instead, the entire microbial community shifts. Lactobacillus populations decline, and a diverse mix of anaerobic bacteria fills the gap. The organisms most commonly associated with BV include Gardnerella vaginalis, various Prevotella species, Mobiluncus, Mycoplasma hominis, and several types of Peptostreptococcus.3PubMed Central. Bacterial vaginosis These bacteria thrive at higher pH levels and produce the volatile amines responsible for the characteristic fishy smell.
One reason BV is so stubborn is that these organisms do not just float around individually. They build a polymicrobial biofilm on the vaginal lining, a structured community of bacteria encased in a protective matrix. This biofilm shields the bacteria from both the immune system and antibiotics, which helps explain why standard treatments clear symptoms but often fail to prevent the condition from coming back.4PubMed Central. Fighting polymicrobial biofilms in bacterial vaginosis.
The immune response during BV also shifts in measurable ways. Studies have found that certain inflammatory markers, particularly the cytokine IL-1β, tend to be elevated in women with BV, while protective antimicrobial peptides are reduced.5PubMed Central. Bacterial vaginosis and the cervicovaginal immune response This disrupted immune environment may make the vaginal lining more vulnerable to other infections, a concern that becomes especially relevant when discussing BV’s downstream health risks.
Known Risk Factors and Triggers
Researchers have identified several factors that increase the likelihood of developing BV, though in many cases no single clear trigger can be pinpointed. The condition often seems to result from a combination of influences acting on the vaginal ecosystem.
Vaginal Douching
Douching is one of the most consistently identified risk factors. A longitudinal study found that regular douching raised the risk of BV by about 21% compared to not douching.6PubMed Central. A Longitudinal Study of Vaginal Douching and Bacterial Vaginosis—A Marginal Structural Modeling Analysis Another study found the risk was highest among women who had douched within the previous seven days, with roughly double the odds of BV compared to non-douchers.7PubMed. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina The reason is straightforward: douching flushes out both harmful and protective bacteria, and the Lactobacillus populations that maintain acidity are slow to recover. Women who douched for “hygiene” and women who douched to treat symptoms both showed increased risk, which is ironic given that many women douche specifically because they are bothered by BV-related odor.
The effect may be strongest in women whose vaginal flora is already somewhat compromised. A prospective study found that douching raised BV risk among women who already had an intermediate flora but did not significantly increase risk among women with a fully normal, Lactobacillus-dominant community.8PubMed. Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora In other words, if your microbiome is already on the edge, douching can push it over.
The Menstrual Cycle
BV prevalence fluctuates with the menstrual cycle. Studies have found higher frequencies of BV in the first and second weeks of the cycle relative to later phases.9PubMed Central. Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women Menstrual blood raises vaginal pH, creating a temporary environment more hospitable to anaerobic bacteria. A 2024 study that tracked daily microbiome changes classified women into four patterns of vaginal community dynamics. Some women maintained a stable, healthy microbiome throughout their cycle, while others showed disruption specifically tied to menstruation, and still others had persistently or unstably disrupted communities.10PubMed Central. Defining Vaginal Community Dynamics: daily microbiome transitions, the role of menstruation, bacteriophages, and bacterial genes These patterns appear to be fairly individual and consistent over time, meaning some women are inherently more susceptible to menstruation-related BV than others.
Sexual Activity and Partner Exchange
BV has long occupied an awkward category: it behaves in some ways like a sexually transmitted condition but does not fit neatly into that classification. It occurs in women who have never had sex, yet new sexual partners and unprotected intercourse clearly raise the risk. Research over the past decade has started to clarify this by looking at the microbiomes of sexual partners together.
In monogamous heterosexual couples where the woman had BV, the bacteria on the male partner’s penile skin and in his urethra were significantly more similar to the woman’s vaginal bacteria than in couples without BV.11PubMed Central. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis A study from Uganda went further, finding that the uncircumcised penis is an important reservoir for BV-associated anaerobic bacteria, and that men reporting extramarital sexual relationships carried more of these organisms.12PubMed Central. Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda This has led researchers to suggest that BV-associated bacteria are sexually transmissible even if BV itself is not a classic sexually transmitted infection. The distinction matters because it means barrier methods and potentially treating male partners could reduce recurrence, something that is now being tested in clinical trials.
Smoking and Hormonal Contraception
Smoking has consistently been linked to higher BV rates, and hormonal contraception appears to be protective. One study found that women using hormonal contraception had about 40% lower odds of BV, while consistent condom users had about half the odds compared to inconsistent users.13Sexually Transmitted Infections. Social and sexual risk factors for bacterial vaginosis The mechanism behind hormonal contraception’s protective effect likely relates to its influence on estrogen levels, which promote glycogen production in vaginal cells, feeding the Lactobacillus bacteria that keep the environment acidic.
Symptoms and When You Might Not Have Any
The hallmark symptoms of BV are a thin, grayish-white vaginal discharge and a noticeable fishy odor, often stronger after sex or during menstruation. Some women also experience mild itching or burning. But a substantial number of women with BV are completely asymptomatic, with no discharge or odor at all, which complicates both diagnosis and treatment decisions.14Nature. Ethnic disparity in diagnosing asymptomatic bacterial vaginosis using machine learning
Clinicians typically diagnose BV using one of two approaches. Amsel’s criteria rely on clinical signs: the character of the discharge, a pH above 4.5, the presence of “clue cells” on a wet mount, and a positive whiff test. Nugent scoring, considered the gold standard, involves microscopic examination of a vaginal smear to assess the ratio of Lactobacillus to BV-associated bacterial types. When compared head to head, Amsel’s criteria have reasonably high specificity (they are good at confirming BV when it is present) but more modest sensitivity (they miss some cases).15PubMed Central. Comparative study of Amsel’s criteria and Nugent scoring for diagnosis of bacterial vaginosis in a tertiary care hospital, Nepal Newer molecular tests using PCR technology can achieve higher detection rates, with one assay reaching about 81% sensitivity while maintaining specificity above 92%.16PubMed. Comparison of Amsel criteria, Nugent score, culture and two CE-IVD marked quantitative real-time PCRs with microbiota analysis for the diagnosis of bacterial vaginosis
Treatment and the Recurrence Problem
Standard BV treatment uses antibiotics, most commonly metronidazole (oral or vaginal gel) or clindamycin vaginal cream. These options perform similarly, with initial cure rates in the range of 75% to 86%.17PubMed. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream That sounds reassuring until you learn about what happens next.
Recurrence is BV’s defining frustration. A large proportion of women experience BV again within months of treatment. The reasons are not fully understood, but two main explanations have emerged: the biofilm left behind after antibiotics allows BV-associated bacteria to re-emerge, and sexual reinfection from a partner who harbors the same organisms undoes the treatment.18PubMed Central. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment DNA testing after clinical cure has shown that Gardnerella vaginalis can persist even when symptoms resolve, which would explain why BV keeps coming back.17PubMed. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream
Strategies to Reduce Your Risk
Because BV is driven by ecological disruption rather than a single pathogen, prevention is less about avoiding one specific thing and more about protecting the conditions that let Lactobacillus thrive.
Stop Douching
This is the single most actionable step. The vagina is self-cleaning, and introducing any liquid, whether it is water, vinegar, or a commercial douche product, disrupts the microbial balance. Given the consistent evidence linking douching to BV, most medical guidelines now advise against it entirely.
Condom Use
Consistent condom use appears protective, but the benefit depends on your starting point. Among women who did not already have BV, consistent condom use was associated with about a 38% lower six-month prevalence of the condition compared to inconsistent use. However, among women who already had BV at baseline, consistent condom use did not significantly change outcomes.19PubMed Central. Effect of consistent condom use on six-month prevalence of bacterial vaginosis varies by baseline BV status This makes sense if you think about condoms as preventing introduction of new BV-associated bacteria rather than resolving an existing imbalance.
Probiotics
Using Lactobacillus-based probiotics alongside or after antibiotic treatment has shown promise for reducing recurrence. In a double-blind, placebo-controlled trial, women who received vaginal probiotic capsules after antibiotic treatment had a recurrence rate of about 16% over two months, compared to 45% in the placebo group.20PubMed. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study A systematic review identified Lactobacillus rhamnosus as the most effective strain tested, with other strains like L. crispatus, L. plantarum, and L. acidophilus also showing potential at varying doses and durations.21PubMed Central. Effective probiotic regimens for bacterial vaginosis treatment and recurrence prevention: A systematic review Dose, route, and treatment duration vary widely across studies, and there is no single standardized protocol yet, but the overall direction of evidence supports probiotics as a useful add-on, particularly for women dealing with repeated episodes.22PubMed. Probiotics for preventing recurrent bacterial vaginosis
Other Adjunct Treatments
Intravaginal boric acid has gained attention for recurrent BV, particularly in online health communities. A recent study of women with a history of multiple BV episodes found that a 14-day course of boric acid suppositories significantly improved diagnostic scores, and nearly 89% of participants achieved scores consistent with a healthy flora afterward. Vaginal odor dropped from 92% of participants at the start to under 2% after treatment, and side effects were mild.23PubMed Central. Intravaginal boric acid treatment for recurrent bacterial vaginosis: short-term effects on vaginal health parameters and patient satisfaction It is worth noting, though, that this study did not include a control group, so the results need to be interpreted cautiously. Lactic acid vaginal gel has also been studied as an alternative to antibiotics. While it performed worse than metronidazole at achieving microbiological cure in the short term, it matched metronidazole for symptom improvement and BV recurrence prevention over six months.24PubMed Central. Effectiveness and tolerability of lactic acid vaginal gel compared to oral metronidazole in the treatment of acute symptomatic bacterial vaginosis: a multicenter, randomized-controlled, head-to-head pilot study
Diet and Nutrient Intake
A less discussed angle on BV prevention involves what you eat. Several studies have found links between nutrient intake and BV risk. Higher dietary fat intake has been associated with increased odds of BV, while higher intakes of folate, vitamin E, and calcium were associated with reduced risk of severe BV.25PubMed Central. Dietary intake of selected nutrients affects bacterial vaginosis in women A case-control study found that women eating a pattern characterized by high consumption of processed foods had over three times the odds of BV compared to those eating the least of that pattern, while an egg-and-vegetable-heavy dietary pattern was associated with substantially lower odds.26Scientific Reports. Association between dietary patterns and bacterial vaginosis: a case–control study Deficiencies in vitamin D and calcium have also been flagged as potential contributors.27PubMed Central. Dietary Influence on Bacterial Vaginosis
The mechanisms behind these associations are not fully worked out. One possibility is that certain nutrients influence the systemic immune environment in ways that trickle down to vaginal mucosal defenses. Another is that diet shapes the gut microbiome, which can in turn influence vaginal microbial communities through bacterial migration. These studies are largely observational, so they cannot prove causation, but they suggest that a nutrient-rich diet heavy on vegetables, whole grains, and adequate vitamins could play a supportive role in vaginal health alongside more targeted interventions.
Why BV Matters Beyond Discomfort
BV is not just an annoyance. It carries real health consequences, especially during pregnancy. A meta-analysis found that BV is associated with roughly double the odds of preterm delivery.28PubMed. Effect of bacterial vaginosis on preterm birth: a meta-analysis BV during pregnancy has also been linked to early miscarriage, postpartum endometritis, and low birth weight.29JAMA. Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement The risk appears to be highest when BV involves specific organisms like Bacteroides species and Mycoplasma hominis together.30PubMed. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant
Outside of pregnancy, BV increases vulnerability to sexually transmitted infections. The disrupted mucosal barrier and heightened inflammation make it easier for pathogens to gain a foothold. A meta-analysis of published studies found that BV was associated with a 60% increase in the risk of acquiring HIV.31PubMed Central. Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies The mechanisms behind this include BV-related disruption of the mucosal barrier and increased production of pro-inflammatory cytokines that can actually attract the immune cells HIV targets.32PubMed Central. The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract These downstream risks are an important reason to take BV seriously even when symptoms are mild or absent.
Why Humans Are Uniquely Vulnerable
One of the more surprising findings from comparative biology is that BV, at least in the way humans experience it, appears to be a distinctly human problem. While Lactobacillus typically makes up over 70% of the human vaginal microbiome, in other mammals lactobacilli rarely account for more than 1%.33PubMed Central. Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique? Other primates have more diverse vaginal communities and higher vaginal pH levels (around 5.5 to 6.5 compared to below 4.5 in humans), yet they rely on different defense mechanisms, including differences in cervical anatomy, to protect against genital infections.34Scientific Reports. Vaginal Dysbiosis from an Evolutionary Perspective
The evolutionary reasons for this unusual dependence on Lactobacillus are still debated. One leading hypothesis ties it to the high glycogen content of the human vaginal epithelium, driven by estrogen. Human vaginal cells deposit large amounts of glycogen, which Lactobacillus species ferment into lactic acid. This may have co-evolved as a particularly effective defense mechanism in a species with concealed ovulation and frequent non-reproductive sexual activity, where pathogen exposure through intercourse is more constant than in species with strict mating seasons. Whatever the evolutionary story, the practical consequence is that humans have built their vaginal defenses around a single genus of bacteria, and when that genus falters, the whole system is vulnerable in a way that other mammals simply are not.